EBS
Emergent BioSolutions Inc.
NYSE · USHealthcareDrug Manufacturers - Specialty & Generic
$7.69+0.79%
Price as of Jul 20, 2026
EBS valuation
Emergent BioSolutions Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 4.11x
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 17.70x
- P/S forward
- 0.68x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.76x
- Price / sales
- 0.59x
- Price / cash flow
- 2.68x
Enterprise value
- Enterprise value
- $810.1M
- EV / sales
- 1.20x
- EV / EBITDA
- 5.24x
- EV / EBIT
- 11.38x
- Market cap
- $396.8M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.